HGF, hepatocyte growth factor, 3082

N. diseases: 671; N. variants: 22
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0019189
Disease: Hepatitis, Chronic
Hepatitis, Chronic
0.350 Biomarker disease CTD_human COMMD1-deficient dogs accumulate copper in hepatocytes and provide a good model for chronic hepatitis and fibrosis. 22879914 2012
CUI: C0019189
Disease: Hepatitis, Chronic
Hepatitis, Chronic
0.350 Biomarker disease BEFREE In conclusion, inhibitory and apoptotic effects of adenoviral HGF gene transduction in hepatomas in contrast to potent mitogenic and antiapoptotic effects of HGF for hepatocytes are not only of biological interest, but also pose clinical benefits for adenoviral HGF gene therapy for CH and LC. 15942646 2005
CUI: C0019189
Disease: Hepatitis, Chronic
Hepatitis, Chronic
0.350 AlteredExpression disease LHGDN Hepatocyte growth factor activates endothelial proangiogenic mechanisms relevant in chronic hepatitis C-associated neoangiogenesis. 12713878 2003
CUI: C0019189
Disease: Hepatitis, Chronic
Hepatitis, Chronic
0.350 AlteredExpression disease LHGDN Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases. 12209727 2002
CUI: C0019189
Disease: Hepatitis, Chronic
Hepatitis, Chronic
0.350 AlteredExpression disease BEFREE Although further study is necessary, the high serum level of HGF revealed high carcinogenic states in chronic hepatitis and liver cirrhosis type C. 11223718 2001
CUI: C0019189
Disease: Hepatitis, Chronic
Hepatitis, Chronic
0.350 Biomarker disease BEFREE Mean values for serum HGF in acute hepatitis (AH), chronic hepatitis (CH), liver cirrhosis (LC), hepatocellular carcinoma (HCC), primary biliary cirrhosis (PBC), fulminant hepatic failure (FHF), and normal controls were 0.45, 0.40, 1.05, 1.06, 0.44, 16.40, and 0.27 ng/mL, respectively. 7806142 1995